Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-03-2016 | Letter to the Editor

Comments on Kristensen et al.: Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients

Authors: Betül Vatankulu, Sabire Yilmaz Aksoy, Sait Sager, Metin Halaç

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 3/2016

Excerpt

Dear Sir, …

Kristensen SB, Hess S, Petersen H, Høilund-Carlsen PF. Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients. Eur J Nucl Med Mol Imaging. 2015;42:2056–63.PubMedCrossRef

Vatankulu B, Yilmaz Aksoy S, Asa S, Sager S, Sayman HB, Halac M, et al. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes. Rev Esp Med Nucl Imagen Mol. 2015. doi:10.1016/j.remn.2015.07.001.

Butros SR, McDermott S, Shelly MJ, Blake MA. Positron emission tomography and computed tomography of the hollow viscera. In: Gore R, Levine M, editors. Textbook of gastrointestinal radiology, 2nd ed. Philadelphia: Saunders; 2015. p. 101.

Sherry SJ, Tahari AK, Sahar M, Andrew C, Subramaniam RM. FDG-PET/CT in the evaluation of paraneoplastic neurologic syndromes. Imaging Med. 2014;6:117–26.CrossRef

Hadjivassiliou M, Alder SJ, Van Beek EJ, Hanney MB, Lorenz E, Rao DG, et al. PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unit. Acta Neurol Scand. 2009;119:186–93.PubMedCrossRef

Matsuhisa A, Toriihara A, Kubota K, Makino T, Mizusawa H, Shibuya H. Utility of F-18 FDG PET/CT in screening for paraneoplastic neurological syndromes. Clin Nucl Med. 2012;37:39–43.PubMedCrossRef

Vaidyanathan S, Pennington C, Ng CY, Poon FW, Han S. 18F-FDG PET-CT in the evaluation of paraneoplastic syndromes: experience at a regional oncology centre. Nucl Med Commun. 2012;33:872–80.PubMedCrossRef

Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABAergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med. 1990;322:1555–60.PubMedCrossRef

Title: Comments on Kristensen et al.: Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients
Authors: Betül Vatankulu
Sabire Yilmaz Aksoy
Sait Sager
Metin Halaç
Publication date: 01-03-2016
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 3/2016
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-015-3284-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Comments on Kristensen et al.: Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2016

Clinical impact of 99mTc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with 90Y-loaded microspheres

A simple method for determining split renal function from dynamic 99mTc-MAG3 scintigraphic data

Reply to: “Comments on Kristensen et al.: Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients”

Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT

Nuclear medicine training in the European Union: 2015 update

High treatment efficacy by dual targeting of Burkitt’s lymphoma xenografted mice with a 177Lu-based CD22-specific radioimmunoconjugate and rituximab